HSA — authorised 18 August 2023
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Status: likely_approved
🇸🇬 Veopoz in Singapore
HSA authorised Veopoz on 18 August 2023
Marketing authorisation
Veopoz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Singapore
Frequently asked questions
Is Veopoz approved in Singapore?
Yes. HSA authorised it on 18 August 2023.
Who is the marketing authorisation holder for Veopoz in Singapore?
REGENERON PHARMACEUTICALS holds the Singaporean marketing authorisation.